Li, Chao http://orcid.org/0000-0002-1126-0655
Hurley, Amanda
Hu, Wei
Warrick, Jay W.
Lozano, Gabriel L.
Ayuso, Jose M.
Pan, Wenxiao http://orcid.org/0000-0002-2252-7888
Handelsman, Jo
Beebe, David J. http://orcid.org/0000-0002-0415-9006
Funding for this research was provided by:
National Science Foundation (EFRI-1136903-EFRI-MKS, MCB-1243671)
U.S. Department of Health & Human Services | National Institutes of Health (R01 EB010039 BRG, R01 CA185251, R01 CA186134, R01 CA181648)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Environmental Protection Agency (H-MAP 83573701)
American Cancer Society (IRG-15-213-51)
U.S. Department of Agriculture (NIFA Postdoctoral Fellowship grant no. 2019-2018-08058/accession no. 1019190)
Article History
Received: 11 February 2020
Accepted: 9 July 2021
First Online: 29 September 2021
Competing interests
: D.J.B., J.H. and A.H. have potential competing interests related to technologies presented here. D.J.B. holds equity in BellBrook Labs LLC, Tasso Inc., Stacks to the Future LLC, Lynx Biosciences LLC, Onexio Biosystems LLC, Turba LLC, Flambeau Diagnostics LLC, and Salus Discovery LLC. D.J.B. is a consultant for Abbott Laboratories. J.H. and A.H. hold equity in Wacasa, Inc. J.H. is a consultant for Phylagen, Inc. The remaining authors declare no competing interests.